WALTHAM, Mass.–(BUSINESS WIRE)–Avedro completes new $32M round of financing led by new investors InterWest and OrbiMed. New round of financing is focused on global corneal cross-linking opportunity.
Uncategorized
Uncategorized
IRIS Registry advances science of ophthalmology
LAS VEGAS — The American Academy’s IRIS Registry is an industry game changer and advances the science of ophthalmology, according to a speaker here. The Intelligence Research in Sight (IRIS) Registry is the nation’s first eye disease clinical database.
Clarity Announces Commercial Availability of HOLOS IntraOpTM Technology
LAS VEGAS–(BUSINESS WIRE)–Clarity Medical Systems, Inc. (Clarity), a medical device company focused on the manufacture of integrated optical systems for the diagnosis and management of eye disorders, announces the commercial availability of its HOLOS…
Uncategorized
Allergan seeks approval for preservative-free Restasis
Allergan announced it has submitted a Prior Approval Supplement for Restasis 0.05% to obtain marketing clearance for a multidose preservative-free formulation.According to the company press release, if the new presentation of Restasis (cyclosporine oph…
Uncategorized
Chairman delivers year’s industry highlights at OIS
LAS VEGAS — This year has been an innovative year in ophthalmology with several milestones being reached, including a number of FDA submissions and successful phase 3 clinical trials, according to Emmett T. Cunningham Jr., MD, PhD, MPH, who gave the “Chairman’s 2015 Year in Review” at the Ophthalmology Innovation Summit here. Spark Therapeutics reported clinical results for RPE-65, the first phase 3 clinical trial for gene therapy for the eye. AbbVie also reported positive phase 3 trial results for Humira (adalimumab) for treatment of noninfectious uveitis.
Tobii AB: Tobii Receives Order for Eye-Tracking Platforms from MSI
STOCKHOLM–(BUSINESS WIRE)–Regulatory News: Tobii AB (Nasdaq Stockholm: TOBII) has received the first purchase order from Micro-Star International Co. Ltd (MSI) for its eye-tracking platform Tobii IS3. The platforms are to be used in premium gaming notebooks from MSI. Deliveries are planned to begin at the turn of 2015/2016. “This order is for integration of eye tracking in a high-end gaming notebook. This means that the initial volume is low, however it’s still an important milestone since it